Immix Biopharma Inc. (IMMX)

1.75

0.17 (10.76%)

At close: Feb 28, 2025, 3:59 PM

1.73

-0.98%

After-hours: Feb 28, 2025, 05:18 PM EST

Immix Biopharma Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-15.6M	-8.23M	-24.38M	-1.15M	-972.81K
Depreciation & Amortization	5.47K	2.13K	2.47K	2.32K	1.08K
Stock-Based Compensation	2.57M	624.07K	218.98K	n/a	n/a
Other Working Capital	-781.56K	-936.53K	-284.97K	169.68K	58.74K
Other Non-Cash Items	n/a	100K	118.16K	575K	-84.5K
Deferred Income Tax	n/a	n/a	22.85M	n/a	n/a
Change in Working Capital	1.65M	195.21K	-391.04K	165.85K	181.7K
Operating Cash Flow	-11.37M	-7.41M	-1.59M	-404.69K	-790.03K
Capital Expenditures	-52.09K	n/a	-802	n/a	-7.31K
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-802	n/a	n/a
Investing Cash Flow	-52.09K	n/a	-802	n/a	-7.31K
Debt Repayment	n/a	n/a	200K	n/a	1.05M
Common Stock Repurchased	n/a	-99.96K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-229.38K	-56.72K	n/a	n/a	n/a
Financial Cash Flow	15.46M	3.23M	18.85M	n/a	1.05M
Net Cash Flow	4.07M	-4.21M	17.25M	-342.93K	271.69K
Free Cash Flow	-11.42M	-7.41M	-1.59M	-404.69K	-797.34K